Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER ; volume:8 ; number:3 ; day:18 ; month:4 ; year:2006 ; pages:1-9 ; date:6.2006
Arthritis Research & Therapy ; 8, Heft 3 (18.4.2006), 1-9, 6.2006
- Creator
-
Carmona, Loreto
- Contributor
-
Gómez-Reino, Juan J.
SpringerLink (Online service)
- DOI
-
10.1186/ar1941
- URN
-
urn:nbn:de:1111-201605034625
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carmona, Loreto
- Gómez-Reino, Juan J.
- SpringerLink (Online service)
Other Objects (12)
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Leukotriene Receptor Antagonists
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry
Malignancy validation in a United States registry of rheumatoid arthritis patients
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Leukotriene Receptor Antagonists
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry
Malignancy validation in a United States registry of rheumatoid arthritis patients
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Leukotriene Receptor Antagonists
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry